Clinical Trial Update: Pharmacologic Augmentation of TMS for Depression With D-serine [Phase 1]

View source ↗

Summary

A Phase 1 trial is assessing whether D-serine can augment transcranial magnetic stimulation for depression and it is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• D-serine (D-serine)

Snippet

Sponsor: Mclean Hospital | Conditions: Depression | Phase 1 | Status: RECRUITING